Opioids in cancer pain / edited by Mellar Davis, Paul Glare and Janet Hardy

Colaborador(es): Glare, Paul [editor literario] | Davis, Mellar [editor literario] | Hardy, janet [editor literario]Tipo de material: TextoTextoDetalles de publicación: Oxford : Oxford University Press, 2005 Descripción: XI, 337 p. ; 24 cmISBN: 0-19-852943-0Tema(s): Drogas -- Uso terapéutico | Cáncer -- Tratamiento | QuimioterapiaResumen: Aids understanding of opioids by providing comprehensive guidelines on pharmacokinetics, dosing schedules, and tolerance. The first book dedicated to opioids in cancer pain management which covers equianalgesia, opioid choices, and dosing strategies. Includes an evidence-based review of each opioid to provide clinically relevant pharmacology which influences opioid choices. There is a great deal of interest in the effective use of opioids for cancer pain due to concerns from both clinicians and patients about addiction. When used correctly, opioids are capable of relieving pain in more than 90% of cancer patients. In reality, patients world-wide continue to endure pain usually due to irrational fears about using them. Fear of addiction is fed by outdated knowledge about opioids and the unintended effects of the war on drugs. However, new research shows that using opioids appropriately for pain management is effective, safe, and has an extremely low potential to produce addiction. This book provides evidence (on which guidelines can be based) from an international group of editors and contributors on opioids in cancer pain management, aimed at palliative care doctors, pharmacists, pain specialists, and oncologists. It includes information on opioid pharmacokinetics as a basis for understanding opioid analgesia, dosing schedule, polymorphisms of analgesic receptors in relationship to tolerance, and intrinsic efficacy. The main body of the book covers individual opioids. Topics within each chapter include structure, pharmacokinetics, pharmacodynamics, routes of administration, toxicity, drug interactions and influences of dosing and kinetics related to organ function. A chapter is dedicated to the WHO analgesic guidelines and opioid choices.Resumen: Índice: 1 Mellar Davis: Introduction. 2 Gavril Pasternak and Mellar Davis:Opioid receptors in analgesia. 3 Kenneth Jackson: Opioid clinical pharmacokinetics. 4 Janet Hardy: Opioids: Codeine. 5 Mellar Davis: Opioids: Hydrocodone. 6 Mellar Davis: Opioids: Tramadol. 7 Paul Glare: Opioids: Dextroproxyphene. 8 Paul Glare: Opioids - Morphine. 9 Paul Glare: Opioids: Hydromorphone. 10 Mellar Davis: Opioids: Oxycodone. 11 Janet Hardy and Tony Hall: Lipophilic Opioids. 12 Mellar Davis: Opioids: Methadone. 13 Mellar Davis: Opioids: Levodromoran. 14 Janet Hardy: Opioids: Diamorphine. 15 Paul Glare: Opioids: Oxymorphone. 16 P... Etc.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Inicie sesión para agregar etiquetas.
Valoración
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca de origen Signatura URL Estado Fecha de vencimiento Código de barras Reserva de ítems
Monografías 04. BIBLIOTECA CIENCIAS DE LA SALUD
3208/01/OPI (Navegar estantería(Abre debajo)) Texto completo Disponible   Ubicación en estantería | Bibliomaps® 3741627854
Total de reservas: 0

Indice

Bibliografía: p. 322-330

Aids understanding of opioids by providing comprehensive guidelines on pharmacokinetics, dosing schedules, and tolerance. The first book dedicated to opioids in cancer pain management which covers equianalgesia, opioid choices, and dosing strategies. Includes an evidence-based review of each opioid to provide clinically relevant pharmacology which influences opioid choices. There is a great deal of interest in the effective use of opioids for cancer pain due to concerns from both clinicians and patients about addiction. When used correctly, opioids are capable of relieving pain in more than 90% of cancer patients. In reality, patients world-wide continue to endure pain usually due to irrational fears about using them. Fear of addiction is fed by outdated knowledge about opioids and the unintended effects of the war on drugs. However, new research shows that using opioids appropriately for pain management is effective, safe, and has an extremely low potential to produce addiction. This book provides evidence (on which guidelines can be based) from an international group of editors and contributors on opioids in cancer pain management, aimed at palliative care doctors, pharmacists, pain specialists, and oncologists. It includes information on opioid pharmacokinetics as a basis for understanding opioid analgesia, dosing schedule, polymorphisms of analgesic receptors in relationship to tolerance, and intrinsic efficacy. The main body of the book covers individual opioids. Topics within each chapter include structure, pharmacokinetics, pharmacodynamics, routes of administration, toxicity, drug interactions and influences of dosing and kinetics related to organ function. A chapter is dedicated to the WHO analgesic guidelines and opioid choices.

Índice: 1 Mellar Davis: Introduction. 2 Gavril Pasternak and Mellar Davis:Opioid receptors in analgesia. 3 Kenneth Jackson: Opioid clinical pharmacokinetics. 4 Janet Hardy: Opioids: Codeine. 5 Mellar Davis: Opioids: Hydrocodone. 6 Mellar Davis: Opioids: Tramadol. 7 Paul Glare: Opioids: Dextroproxyphene. 8 Paul Glare: Opioids - Morphine. 9 Paul Glare: Opioids: Hydromorphone. 10 Mellar Davis: Opioids: Oxycodone. 11 Janet Hardy and Tony Hall: Lipophilic Opioids. 12 Mellar Davis: Opioids: Methadone. 13 Mellar Davis: Opioids: Levodromoran. 14 Janet Hardy: Opioids: Diamorphine. 15 Paul Glare: Opioids: Oxymorphone. 16 P... Etc.

No hay comentarios en este titulo.

para aportar su opinión.

Con tecnología Koha